Message below is a paid advertisement. Content is provided by the sponsor.
 
A SPECIAL
ANNOUNCEMENT FROM:
  ACT Logo  
Clinical Trial Simulation: An Efficient Tool for Improved Study Designs, Dose Selection and Go/No-go Investment Decisions
LIVE WEBCAST
Europe: Tuesday, September 19, 2017 at 2pm BST | 3pm CEST
North America: Thursday, September 28, 2017 at 10am EDT | 9am CDT
Click to register for this free webcast »
Event Overview
Proposed study designs and dosing recommendations can be evaluated and compared, using model-based simulation. By integrating available in-house and literature data in mathematical dose-exposure-response (therapeutic and adverse) models, the expected influence of various key factors on study outcome, can be explored. Non-informative study designs and sub-optimal dosing regimens may thereby be avoided, reducing cost and development times. In addition, clinical trial simulations optimize the company go/no-go decision making process and support its arguments and quantitative evidence in regulatory interactions. In this webcast, industry experts will provide the concepts around clinical trial simulation and present through case studies how modelling and simulation can expedite drugs from early to late stages of development across different therapeutic areas.

The webcast will address:
  • How can PK/PD and drug-disease models be used for making inference?
  • What is the impact of mechanistic vs empirical model, longitudinal vs fix time-point analyses, uncertainty, sub-populations, between- and within-subject variability?
  • When should the probability of a successful study outcome be simulated?
  • Why can this methodology improve internal and regulatory decision-making?
Key Learning Objectives
  • How clinical trial simulation can be used to justify study design
  • Why model-based simulations should guide dose selection
  • Why clinical trial simulation can reduce the risk of failure at Phase III
Who Should Attend
  • Head of R&D
  • Head of Biometrics
  • Clinical Pharmacology & PK/PD Modeling Managers
  • Clinical Research Managers
  • Project Managers
Presenters
Alberto Russu
Alberto Russu
Alberto Russu
Senior Scientist Pharmacometrics,
Global Clinical Pharmacology
Janssen Research and Development
Per Olsson Gisleskog
Per Olsson Gisleskog
Principal Consultant
SGS Exprimo
Lisa Henderson
Moderator
Lisa Henderson
Editorial Director
Applied Clinical Trials
Sponsored by:
SGS
Presented by:
Applied Clinical Trials
Click to register for this free webcast »
 
Have any questions? Contact Kristen Moore at kristen.moore@ubm.com
Subscribe: PrintDigitalEnews
Twitter icon  Linked In icon
You received this email because you are a customer of ACT, a UBM publication. You are on the mailing list as %%emailaddress%%.